| scholarly article | Q13442814 |
| P2093 | author name string | Jing Liu | |
| David R Corey | |||
| Thazha P Prakash | |||
| Jiaxin Hu | |||
| Jessica A Hicks | |||
| P2860 | cites work | Antisense-mediated exon skipping: taking advantage of a trick from Mother Nature to treat rare genetic diseases | Q38184276 |
| Import routes and nuclear functions of Argonaute and other small RNA-silencing proteins. | Q38240731 | ||
| Antisense oligonucleotide-based therapies for diseases caused by pre-mRNA processing defects | Q38247135 | ||
| The influence of Argonaute proteins on alternative RNA splicing | Q38254276 | ||
| Comparative analysis of antisense oligonucleotide sequences for targeted skipping of exon 51 during dystrophin pre-mRNA splicing in human muscle | Q40177871 | ||
| Human nuclear Dicer restricts the deleterious accumulation of endogenous double-stranded RNA. | Q42152387 | ||
| Lipid nanoparticles improve activity of single-stranded siRNA and gapmer antisense oligonucleotides in animals | Q44199808 | ||
| Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study | Q45033314 | ||
| Argonaute proteins couple chromatin silencing to alternative splicing. | Q45345567 | ||
| Specific and potent RNAi in the nucleus of human cells | Q45345569 | ||
| Control of alternative splicing through siRNA-mediated transcriptional gene silencing. | Q45960034 | ||
| Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy. | Q52547202 | ||
| Local dystrophin restoration with antisense oligonucleotide PRO051 | Q80412961 | ||
| Single-stranded siRNAs activate RNAi in animals | Q84913472 | ||
| MicroRNA-373 induces expression of genes with complementary promoter sequences | Q24652547 | ||
| A chemical view of oligonucleotides for exon skipping and related drug applications | Q26863684 | ||
| Structure of an argonaute silencing complex with a seed-containing guide DNA and target RNA duplex | Q27653175 | ||
| Argonaute2 is the catalytic engine of mammalian RNAi | Q27860545 | ||
| RNAi factors are present and active in human cell nuclei | Q28111715 | ||
| Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs | Q33632395 | ||
| Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs | Q33939348 | ||
| Long non-coding RNA targeting and transcriptional de-repression | Q34326761 | ||
| Promoter RNA links transcriptional regulation of inflammatory pathway genes | Q34368214 | ||
| RNA interference in the nucleus: roles for small RNAs in transcription, epigenetics and beyond | Q34385616 | ||
| The varied roles of nuclear argonaute-small RNA complexes and avenues for therapy | Q34440319 | ||
| The status of exon skipping as a therapeutic approach to duchenne muscular dystrophy | Q34473336 | ||
| Argonaute-1 binds transcriptional enhancers and controls constitutive and alternative splicing in human cells | Q34480743 | ||
| Transcriptional gene silencing in mammalian cells by miRNA mimics that target gene promoters | Q35120827 | ||
| Exon-skipping therapy: a roadblock, detour, or bump in the road? | Q35731229 | ||
| Expanding the action of duplex RNAs into the nucleus: redirecting alternative splicing | Q35740521 | ||
| Argonaute and the nuclear RNAs: new pathways for RNA-mediated control of gene expression | Q35867143 | ||
| Single-stranded RNAs use RNAi to potently and allele-selectively inhibit mutant huntingtin expression. | Q36239309 | ||
| MicroRNA-directed transcriptional gene silencing in mammalian cells | Q36945167 | ||
| ss-siRNAs allele selectively inhibit ataxin-3 expression: multiple mechanisms for an alternative gene silencing strategy | Q37271206 | ||
| Transcriptional silencing by single-stranded RNAs targeting a noncoding RNA that overlaps a gene promoter | Q37541625 | ||
| Chromatin remodeling by the small RNA machinery in mammalian cells | Q37591539 | ||
| Intracellular localization and routing of miRNA and RNAi pathway components | Q37971099 | ||
| Targeting mRNA splicing as a potential treatment for Duchenne muscular dystrophy | Q38030657 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 3 | |
| P304 | page(s) | 113-120 | |
| P577 | publication date | 2015-03-10 | |
| P1433 | published in | Nucleic Acid Therapeutics | Q19297428 |
| P1476 | title | Modulation of Splicing by Single-Stranded Silencing RNAs | |
| P478 | volume | 25 |
| Q28080201 | MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions |
| Q90110761 | MicroRNA miR-1002 Enhances NMNAT-Mediated Stress Response by Modulating Alternative Splicing |
| Q38289648 | Recognition of c9orf72 Mutant RNA by Single-Stranded Silencing RNAs |
| Q26776412 | Regulation of mammalian transcription and splicing by Nuclear RNAi |
| Q37015869 | Stable association of RNAi machinery is conserved between the cytoplasm and nucleus of human cells |
Search more.